Carbajal-Mamani Semiramis, Chheda Neil, Esnakula Ashwini, Cardenas-Goicoechea Joel
University of Florida, Department of Medicine, United States.
University of Florida, Department of Otolaryngology, United States.
Gynecol Oncol Rep. 2020 Apr 7;32:100568. doi: 10.1016/j.gore.2020.100568. eCollection 2020 May.
60 year old woman with a history of laryngeal carcinoma-HPV 16 positive, presents seven years later with an abnormal Pap smear. Cervical biopsy showed squamous cell carcinoma. Clinical stage was IB1. Patient underwent open radical hysterectomy and lymphadenectomy. Based on pathologic findings no adjuvant therapy was recommended. Uterine cervix carcinoma was also positive for HPV-16. There are no guidelines for cervical cancer screening in patients with laryngeal cancer and vice versa. Our recommendation is that patient with HPV-positive laryngeal cancer should be encouraged HPV vaccine as current guidelines, but more frequent screening, as recommended for women with specific co-morbid conditions, needs to be investigated. Research is needed to assess the role of screening for laryngeal cancer in women with cervical cancer and the effect of HPV vaccine on laryngeal cancer prevention.
一名60岁女性,有喉癌病史且HPV 16阳性,七年后出现巴氏涂片异常。宫颈活检显示为鳞状细胞癌。临床分期为IB1期。患者接受了开放性根治性子宫切除术和淋巴结清扫术。根据病理结果,不建议进行辅助治疗。子宫颈癌HPV-16也呈阳性。目前尚无针对喉癌患者宫颈癌筛查的指南,反之亦然。我们的建议是,对于HPV阳性的喉癌患者,应按照现行指南鼓励接种HPV疫苗,但对于有特定合并症的女性所推荐的更频繁筛查,还需要进行研究。需要开展研究来评估宫颈癌女性中喉癌筛查的作用以及HPV疫苗对喉癌预防的效果。